MedTrace Logo

Evaluation of a Multidisciplinary Care Pathway on the Evolution of Renal Function in Patients With Advanced Chronic Kidney Disease

NCT06495385 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 535

Last updated 2024-07-10

No results posted yet for this study

Summary

The number of incident and prevalent patients with end stage renal disease on dialysis treatment is increasing in France and worldwide. A quarter of dialysis patients are initiating dialysis urgently through central venous catheters and the number of patients registered in the waiting list for renal transplantation before dialysis initiation is very low. This is also reflected in the very low number of pre-emptive renal transplantations.

In order to reduce the number of dialysis patients, the French state has induced a national program proposing a multidisciplinary care pathway including the nephrology visits and at least one consultation with a dietitian and a specialist renal nurse in all patients with Chronic Kidney Disease stage 4 and 5.

Conditions

  • Chronic Kidney Disease stage4
  • Chronic Kidney Disease Stage 5

Interventions

DIAGNOSTIC_TEST

Evolution of renal function

Plasma creatinine levels and glomerular filtration rate estimated using the CKD-Epi formula adjusted for 1.73 m2 body surface area will be measured.

DIAGNOSTIC_TEST

Measurement of haemoglobin levels

Haemoglobin levels will be measured.

DIAGNOSTIC_TEST

Measurement of biological parameters

Plasma levels of urea, calcium, phosphorus and parathyroid hormone, as well as alkaline reserve, will be measured.

DIAGNOSTIC_TEST

Measure sodium and protein consumption

24-hour urine volume, proteinuria, urea and sodium, will be measured.

BEHAVIORAL

Quality of life questionnaire EUROQOL 5 dimensions (EQ-5D-5L)

The descriptive system comprises five dimensions: mobility, personal care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 5 levels: no problems, mild problems, moderate problems, severe problems and extreme problems. The figures for the five dimensions can be combined into a 5-digit number describing the patient's state of health. Scores close to 1 indicate "the best health you can imagine" and those close to 0 "the worst health you can imagine".

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Saint Etienne

    lead OTHER

Principal Investigators

  • Hélène PAGES, nurse · CHU de Saint-Etienne

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-09
Primary Completion
2024-05-22
Completion
2024-09-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06495385 on ClinicalTrials.gov